Lv31
330 积分 2023-08-21 加入
Antibody–drug conjugates come of age in oncology
10天前
已完结
Antisense technology: an overview and prospectus
20天前
已完结
Givosiran in acute intermittent porphyria: A personalized medicine approach
25天前
已完结
STING activation and overcoming the challenges associated with STING agonists using ADC (antibody-drug conjugate) and other delivery systems
26天前
已完结
RNAi-based drug design: considerations and future directions
28天前
已完结
RNA-targeting and gene editing therapies for transthyretin amyloidosis
29天前
已完结
Transthyretin: the servant of many masters
1个月前
已完结
Cardiac Amyloidosis Due to Transthyretin Protein
1个月前
已完结
Suspecting and diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) in India: An Indian expert consensus
1个月前
已完结
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
1个月前
已完结
皖公网安备34019202002308
